Literature DB >> 20458507

The sympathetic-vagal balance against endotoxemia.

Jian Huang1, Yaoli Wang, Dongbo Jiang, Jian Zhou, Xiankai Huang.   

Abstract

The goal of this study was to establish a convenient and effective approach to anti-inflammation treatment by rebalancing the sympathetic-vagal system via vagal nerve stimulation (VNS). We established an endotoxemia model in Sprague-Dawley rats using lipopolysaccharide (LPS) injection. Electrical discharges in the vagal system, including the nucleus tractus solitarii (NTS) and afferent and efferent cervical vagal nerves, were detected. The condition of sympathetic-vagal balance, presented as heart rate variability (HRV) and hepatic norepinephrine/acetylcholine (NE/ACh), was measured following endotoxemia with and without VNS. Discharges in afferent and efferent vagal nerves increased significantly following LPS injection compared with the basis level and corresponding time points in the control group. Discharges in the NTS also increased significantly following LPS injection. The HRV components, including normalized high frequency (HFnm), normalized low frequency (LFnm), LF/HF, and very low frequency (VLF), increased significantly following LPS injection. HFnm values in the LPS + VNS group increased significantly compared with the LPS group. Conversely, LFnm, LF/HF, and VLF in the LPS + VNS group decreased significantly compared with the LPS group. Hepatic NE and ACh significantly decreased within 6 h after LPS injection compared with the basal level and the control groups (P < 0.05). VNS did not significantly improve hepatic NE, but the ACh levels in the LPS + VNS group were higher than those in other groups. Sympathetic and vagal nervous systems are enhanced following endotoxemia. The overexcitation of the sympathetic system leads to sympathetic-vagal disequilibrium. The rebalance of the sympathetic and vagal system is crucial for critically ill patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20458507     DOI: 10.1007/s00702-010-0407-6

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  25 in total

1.  Immunomodulatory effects of fosfomycin in an endotoxin model in human blood.

Authors:  Markus Zeitlinger; Claudia Marsik; Ilka Steiner; Robert Sauermann; Katja Seir; Bernd Jilma; Oswald Wagner; Christian Joukhadar
Journal:  J Antimicrob Chemother       Date:  2006-11-16       Impact factor: 5.790

2.  Power spectrum analysis of heart rate fluctuations and respiratory movements associated with cooling the human skin.

Authors:  T Kunitake; N Ishiko
Journal:  J Auton Nerv Syst       Date:  1992-04

3.  Intestinal electric stimulation modulates neuronal activity in the nucleus of the solitary tract in rats.

Authors:  Ying Sun; Chao Qin; Robert D Foreman; J D Z Chen
Journal:  Neurosci Lett       Date:  2005-09-02       Impact factor: 3.046

4.  The role of Kupffer cell alpha(2)-adrenoceptors in norepinephrine-induced TNF-alpha production.

Authors:  M Zhou; S Yang; D J Koo; D A Ornan; I H Chaudry; P Wang
Journal:  Biochim Biophys Acta       Date:  2001-07-27

5.  Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome.

Authors:  H A Sackeim; A J Rush; M S George; L B Marangell; M M Husain; Z Nahas; C R Johnson; S Seidman; C Giller; S Haines; R K Simpson; R R Goodman
Journal:  Neuropsychopharmacology       Date:  2001-11       Impact factor: 7.853

6.  Differential regulatory effects of adenosine on cytokine release by activated human monocytes.

Authors:  M G Bouma; R K Stad; F A van den Wildenberg; W A Buurman
Journal:  J Immunol       Date:  1994-11-01       Impact factor: 5.422

Review 7.  Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug.

Authors:  Andreas Oberholzer; Caroline Oberholzer; Lyle L Moldawer
Journal:  Crit Care Med       Date:  2002-01       Impact factor: 7.598

8.  Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis.

Authors:  Valentin A Pavlov; Mahendar Ochani; Li-Hong Yang; Margot Gallowitsch-Puerta; Kanta Ochani; Xinchun Lin; Jelena Levi; William R Parrish; Mauricio Rosas-Ballina; Christopher J Czura; Gregory J Larosa; Edmund J Miller; Kevin J Tracey; Yousef Al-Abed
Journal:  Crit Care Med       Date:  2007-04       Impact factor: 7.598

9.  Autonomic neuropathy in streptozotocin diabetic rats: effect of acetyl-L-carnitine.

Authors:  Pietro Lo Giudice; Antonia Careddu; Giuseppina Magni; Teresa Quagliata; Licia Pacifici; Paolo Carminati
Journal:  Diabetes Res Clin Pract       Date:  2002-06       Impact factor: 5.602

10.  Comparison between heart rate variability and recovery in ischemic patients.

Authors:  D Zdrenghea; Adela Sitar-Tăut; Dana Pop
Journal:  Rom J Intern Med       Date:  2007
View more
  20 in total

1.  On heart rate variability and autonomic activity in homeostasis and in systemic inflammation.

Authors:  Jeremy D Scheff; Benjamin Griffel; Siobhan A Corbett; Steve E Calvano; Ioannis P Androulakis
Journal:  Math Biosci       Date:  2014-03-26       Impact factor: 2.144

2.  Inhibition of cardiac pacemaker channel hHCN2 depends on intercalation of lipopolysaccharide into channel-containing membrane microdomains.

Authors:  Udo Klöckner; Uwe Rueckschloss; Claudia Grossmann; Saskia Matzat; Katja Schumann; Henning Ebelt; Ursula Müller-Werdan; Harald Loppnow; Karl Werdan; Michael Gekle
Journal:  J Physiol       Date:  2013-12-23       Impact factor: 5.182

3.  Effects of afferent and efferent denervation of vagal nerve on endotoxin-induced oxidative stress in rats.

Authors:  Omar M E Abdel-Salam; Rehab Fawzy Abdel-Rahman; Amany A Sleem; Fatma Adly Mosry; Hafiza A Sharaf
Journal:  J Neural Transm (Vienna)       Date:  2013-06-23       Impact factor: 3.575

4.  Suppression of TLR4/MyD88/TAK1/NF-κB/COX-2 Signaling Pathway in the Central Nervous System by Bexarotene, a Selective RXR Agonist, Prevents Hyperalgesia in the Lipopolysaccharide-Induced Pain Mouse Model.

Authors:  Sefika Pinar Senol; Meryem Temiz-Resitoglu; Demet Sinem Guden; Ayse Nihal Sari; Seyhan Sahan-Firat; Bahar Tunctan
Journal:  Neurochem Res       Date:  2021-01-02       Impact factor: 3.996

5.  Gastric acid secretion and gastrin release during continuous vagal neuromonitoring in thyroid surgery.

Authors:  Liu Xiaoli; Che-Wei Wu; Hoon Yub Kim; Wen Tian; Feng-Yu Chiang; Renbin Liu; Angkoon Anuwong; Gregory W Randolph; Gianlorenzo Dionigi; Matteo Lavazza
Journal:  Langenbecks Arch Surg       Date:  2017-01-19       Impact factor: 3.445

6.  Effects of anti-inflammatory vagus nerve stimulation in endotoxemic rats on blood and spleen lymphocyte subsets.

Authors:  S Mihaylova; H Schweighöfer; H Hackstein; B Rosengarten
Journal:  Inflamm Res       Date:  2014-05-07       Impact factor: 4.575

Review 7.  Translational applications of evaluating physiologic variability in human endotoxemia.

Authors:  Jeremy D Scheff; Panteleimon D Mavroudis; Steve E Calvano; Ioannis P Androulakis
Journal:  J Clin Monit Comput       Date:  2012-12-01       Impact factor: 2.502

8.  Vagal Nerve Stimulation-Modulation of the Anti-Inflammatory Response and Clinical Outcome in Psoriatic Arthritis or Ankylosing Spondylitis.

Authors:  C Brock; S E Rasmussen; A M Drewes; H J Møller; B Brock; B Deleuran; A D Farmer; M Pfeiffer-Jensen
Journal:  Mediators Inflamm       Date:  2021-05-27       Impact factor: 4.711

9.  Transcutaneous auricular vagus nerve stimulation protects endotoxemic rat from lipopolysaccharide-induced inflammation.

Authors:  Yu Xue Zhao; Wei He; Xiang Hong Jing; Jun Ling Liu; Pei Jing Rong; Hui Ben; Kun Liu; Bing Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-29       Impact factor: 2.629

10.  The effect of orexin-A on cardiac dysfunction mediated by NADPH oxidase-derived superoxide anion in ventrolateral medulla.

Authors:  Jun Chen; Chunmei Xia; Jin Wang; Meiyan Jiang; Huanhuan Zhang; Chengrong Zhang; Minxia Zhu; Linlin Shen; Danian Zhu
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.